Relay Therapeutics, Inc. (RLAY) stock analysis

RLAY · Relay Therapeutics, Inc.

Latest recorded price: USD 17.27

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 123.2%, free cash flow margin -1,536.1%, ROIC -54.0%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare